Cabergoline
| CAS No. | 81409-90-7 |
|---|---|
| MDL No. | N/A |
| MF | C26H37N5O2 |
| MW | 451.60 |
| InChI Key | KORNTPPJEAJQIU-KJXAQDMKSA-N |
| CAS No. | 81409-90-7 |
|---|---|
| MDL No. | N/A |
| MF | C26H37N5O2 |
| MW | 451.60 |
| InChI Key | KORNTPPJEAJQIU-KJXAQDMKSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Cabergoline is an N-acylurea, specifically (8R)-ergoline-8-carboxamide, with the piperidine nitrogen (position 6) substituted by an allyl group and the carboxamide nitrogen substituted by a 3-(dimethylamino)propyl group and an N-ethylcarbamoyl group. It is a dopamine D2 receptor agonist used in the management of Parkinson's disease and hyperprolactinaemia-related disorders. It functions as a dopamine agonist, antiparkinson drug, and antineoplastic agent.
| CAS No. | 81409-90-7 |
|---|---|
| Product Name | Cabergoline |